Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.

Proteomic Analysis of Inflammatory Biomarkers Associated With Breast Cancer Recurrence.

Bera A, Russ E, Srinivasan M, Eidelman O, Eklund M, Hueman M, Pollard HB, Hu H, Shriver CD, Srivastava M.

Mil Med. 2020 Jan 7;185(Supplement_1):669-675. doi: 10.1093/milmed/usz254.

PMID:
32074342
2.

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy.

Ström P, Nordström T, Delahunt B, Samaratunga H, Grönberg H, Egevad L, Eklund M.

J Clin Pathol. 2020 Feb 7. pii: jclinpath-2019-206300. doi: 10.1136/jclinpath-2019-206300. [Epub ahead of print]

3.

Evaluation of analytical and statistical approaches for predicting in vitro nitrogen solubility and in vivo pre-caecal crude protein digestibility of cereal grains in growing pigs.

Rosenfelder-Kuon P, Krieg J, Sauer N, Eklund M, Spindler HK, Strang EJP, Siegert W, Rodehutscord M, Schenkel H, Mosenthin R.

J Anim Physiol Anim Nutr (Berl). 2020 Feb 6. doi: 10.1111/jpn.13320. [Epub ahead of print]

PMID:
32027056
4.

A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.

Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, Dong TS, Eklund M, Russ E, Nasser H, Lagishetty V, Guo R, Sajed D, Mudgal S, Mehta P, Avila L, Srivastava M, Faull K, Jacobs J, Pellegrini M, Shin DS, Srivatsan ES, Wang MB.

Cancer. 2020 Feb 5. doi: 10.1002/cncr.32644. [Epub ahead of print]

PMID:
32022261
5.

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.

Ström P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, Wählby C, Grönberg H, Rantalainen M, Egevad L, Eklund M.

Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8. Erratum in: Lancet Oncol. 2020 Feb;21(2):e70.

PMID:
31926806
6.

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.

Chandra Engel J, Palsdottir T, Aly M, Egevad L, Grönberg H, Eklund M, Nordström T.

Scand J Urol. 2019 Dec 26:1-6. doi: 10.1080/21681805.2019.1703806. [Epub ahead of print]

PMID:
31876229
8.

Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction.

Dembrower K, Liu Y, Azizpour H, Eklund M, Smith K, Lindholm P, Strand F.

Radiology. 2020 Feb;294(2):265-272. doi: 10.1148/radiol.2019190872. Epub 2019 Dec 17.

PMID:
31845842
9.

Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson's Disease.

Hultqvist J, Sahlström T, Timpka J, Henriksen T, Nyholm D, Odin P, Eklund M.

Occup Ther Health Care. 2019 Nov 26:1-18. doi: 10.1080/07380577.2019.1692269. [Epub ahead of print]

PMID:
31766928
10.

Description of two Serratia marcescens associated mastitis outbreaks in Finnish dairy farms and a review of literature.

Friman MJ, Eklund MH, Pitkälä AH, Rajala-Schultz PJ, Rantala MHJ.

Acta Vet Scand. 2019 Nov 14;61(1):54. doi: 10.1186/s13028-019-0488-7.

11.

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.

Beckmann K, Crawley D, Nordström T, Aly M, Olsson H, Lantz A, Binti Abd Jalal N, Garmo H, Adolfsson J, Eklund M, Van Hemelrijck M.

JAMA Netw Open. 2019 Nov 1;2(11):e1914689. doi: 10.1001/jamanetworkopen.2019.14689.

12.

The importance of study design in the application of artificial intelligence methods in medicine.

Eklund M, Kartasalo K, Olsson H, Ström P.

NPJ Digit Med. 2019 Oct 18;2:101. doi: 10.1038/s41746-019-0174-1. eCollection 2019. No abstract available.

13.

The proximal hamstring avulsion clinical trial (PHACT)-a randomised controlled non-inferiority trial of operative versus non-operative treatment of proximal hamstrings avulsions: study protocol.

Pihl E, Kristoffersen MH, Rosenlund AM, Laszlo S, Berglöf M, Ribom E, Eriksson K, Frihagen F, Mattila VM, Schilcher J, Eklund M, Snellman G, Skorpil M, Sköldenberg O, Hedbeck CJ, Jonsson K.

BMJ Open. 2019 Sep 13;9(9):e031607. doi: 10.1136/bmjopen-2019-031607.

14.

A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging.

Palsdottir T, Nordström T, Aly M, Jäderling F, Clements M, Grönberg H, Eklund M.

Eur Urol Oncol. 2019 Sep;2(5):490-496. doi: 10.1016/j.euo.2018.09.008. Epub 2018 Oct 9.

15.

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Beckmann K, Kinsella N, Olsson H, Wallerstedt Lantz A, Nordstrom T, Aly M, Adolfsson J, Eklund M, Van Hemelrijck M.

BMC Urol. 2019 Aug 5;19(1):73. doi: 10.1186/s12894-019-0502-4.

16.

The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches.

Eklund M, Broglio K, Yau C, Connor JT, Stover Fiscalini A, Esserman LJ.

JNCI Cancer Spectr. 2019 Jan 8;2(4):pky067. doi: 10.1093/jncics/pky067. eCollection 2018 Oct.

17.

Breaking a cycle of perceived failure: The process of making changes toward a more balanced lifestyle.

Lund K, Argentzell E, Bejerholm U, Eklund M.

Aust Occup Ther J. 2019 Oct;66(5):627-636. doi: 10.1111/1440-1630.12604. Epub 2019 Jul 25.

PMID:
31344759
18.

Early continuous renal replacement therapy during infant extracorporeal life support is associated with decreased lung opacification.

Murphy HJ, Eklund MJ, Hill J, Morella K, Cahill JB, Kiger JR, Twombley KE, Annibale DJ.

J Artif Organs. 2019 Dec;22(4):286-293. doi: 10.1007/s10047-019-01119-1. Epub 2019 Jul 25.

PMID:
31342287
19.

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer.

Olsson H, Nordström T, Clements M, Grönberg H, Lantz AW, Eklund M.

Eur Urol Oncol. 2019 Jun 21. pii: S2588-9311(19)30072-0. doi: 10.1016/j.euo.2019.05.005. [Epub ahead of print]

21.

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study.

Palsdottir T, Nordström T, Aly M, Lindberg J, Clements M, Egevad L, Grönberg H, Eklund M.

PLoS One. 2019 Jun 13;14(6):e0218280. doi: 10.1371/journal.pone.0218280. eCollection 2019.

22.

Perceived occupational balance and well-being among people with mental illness living in two types of supported housing.

Eklund M, Brunt D, Argentzell E.

Scand J Occup Ther. 2019 Jun 7:1-12. doi: 10.1080/11038128.2019.1622771. [Epub ahead of print]

PMID:
31170857
23.

Decreased BDNF in female but not male rats after exposure to stress: a sex-sensitive rat model of stress?

Weisbrod AS, Barry ES, Graham AM, Eklund M, Grunberg NE.

Stress. 2019 Sep;22(5):581-591. doi: 10.1080/10253890.2019.1617692. Epub 2019 May 28.

PMID:
31134851
24.
25.

Phytate degradation, intestinal microbiota, microbial metabolites and immune values are changed in growing pigs fed diets with varying calcium-phosphorus concentration and fermentable substrates.

Heyer CME, Schmucker S, Burbach K, Weiss E, Eklund M, Aumiller T, Capezzone F, Steuber J, Rodehutscord M, Hoelzle LE, Seifert J, Mosenthin R, Stefanski V.

J Anim Physiol Anim Nutr (Berl). 2019 Jul;103(4):1185-1197. doi: 10.1111/jpn.13088. Epub 2019 Apr 1.

PMID:
30934140
26.

The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study.

Palsdottir T, Nordstrom T, Karlsson A, Grönberg H, Clements M, Eklund M.

BMJ Open. 2019 Mar 30;9(3):e027958. doi: 10.1136/bmjopen-2018-027958.

27.

A response to "Personalised medicine and population health: breast and ovarian cancer".

Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E.

Hum Genet. 2019 Mar;138(3):287-289. doi: 10.1007/s00439-019-01984-z. Epub 2019 Feb 27. No abstract available.

28.

A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data.

Karlsson A, Jauhiainen A, Gulati R, Eklund M, Grönberg H, Etzioni R, Clements M.

PLoS One. 2019 Feb 14;14(2):e0211918. doi: 10.1371/journal.pone.0211918. eCollection 2019.

29.

Group leader and participant perceptions of Balancing Everyday Life, a group-based lifestyle intervention for mental health service users.

Lund K, Hultqvist J, Bejerholm U, Argentzell E, Eklund M.

Scand J Occup Ther. 2019 Feb 1:1-12. doi: 10.1080/11038128.2018.1551419. [Epub ahead of print]

PMID:
30706746
30.

Everyday life when growing up with a mother with an intellectual or developmental disability: Four retrospective life-stories.

Weiber I, Tengland PA, Berglund JS, Eklund M.

Scand J Occup Ther. 2019 Jan 20:1-13. doi: 10.1080/11038128.2018.1554087. [Epub ahead of print]

PMID:
30661438
31.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2019 Feb;51(2):363. doi: 10.1038/s41588-018-0330-6.

PMID:
30622367
33.

Response to Walsh.

Ström P, Lantz AW, Grönberg H, Nordström T, Eklund M.

J Natl Cancer Inst. 2018 Oct 30. doi: 10.1093/jnci/djy187. [Epub ahead of print] No abstract available.

PMID:
30380079
34.

Towards Next-generation Urine-based Prostate Cancer Risk Stratification.

Nordström T, Lindberg J, Eklund M.

Eur Urol. 2018 Dec;74(6):739-740. doi: 10.1016/j.eururo.2018.09.024. Epub 2018 Sep 28. No abstract available.

PMID:
30274703
35.

A survey of pediatric diagnostic radiologists in North America: current practices in fetal magnetic resonance imaging.

Chapman T, Alazraki AL, Eklund MJ.

Pediatr Radiol. 2018 Dec;48(13):1924-1935. doi: 10.1007/s00247-018-4236-3. Epub 2018 Sep 3.

PMID:
30178081
36.

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.

Li J, Wen WX, Eklund M, Kvist A, Eriksson M, Christensen HN, Torstensson A, Bajalica-Lagercrantz S, Dunning AM, Decker B, Allen J, Luccarini C, Pooley K, Simard J, Dorling L, Easton DF, Teo SH, Hall P, Borg Å, Grönberg H, Czene K.

Int J Cancer. 2019 Mar 1;144(5):1195-1204. doi: 10.1002/ijc.31841. Epub 2018 Nov 9.

37.

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.

Möller A, Olsson H, Grönberg H, Eklund M, Aly M, Nordström T.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):137-142. doi: 10.1038/s41391-018-0082-5. Epub 2018 Aug 31.

PMID:
30171228
38.

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.

Grönberg H, Eklund M, Picker W, Aly M, Jäderling F, Adolfsson J, Landquist M, Haug ES, Ström P, Carlsson S, Nordström T.

Eur Urol. 2018 Dec;74(6):722-728. doi: 10.1016/j.eururo.2018.06.022. Epub 2018 Jul 9.

PMID:
30001824
39.

Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015.

Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, Rantala M.

Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1700497.

40.

Predictors of participation in risk-based prostate cancer screening.

Koitsalu M, Eklund M, Adolfsson J, Sprangers MAG, Grönberg H, Brandberg Y.

PLoS One. 2018 Jul 10;13(7):e0200409. doi: 10.1371/journal.pone.0200409. eCollection 2018.

41.
42.

High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer.

Leighton X, Bera A, Eidelman O, Eklund M, Puthillathu N, Pollard HB, Srivastava M.

Anticancer Res. 2018 Jul;38(7):3831-3842. doi: 10.21873/anticanres.12667.

PMID:
29970503
43.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z.

Nat Commun. 2018 Jun 11;9(1):2256. doi: 10.1038/s41467-018-04109-8.

44.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium.

Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11. Erratum in: Nat Genet. 2019 Feb;51(2):363.

45.

Quality of life among people with psychiatric disabilities attending community-based day centres or Clubhouses.

Hultqvist J, Markström U, Tjörnstrand C, Eklund M.

Scand J Caring Sci. 2018 Dec;32(4):1418-1427. doi: 10.1111/scs.12587. Epub 2018 Jun 8.

PMID:
29882589
46.

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.

Vickers A, Nordström T, Assel M, Lilja H, Grönberg H, Eklund M.

Eur Urol. 2018 Aug;74(2):e35-e36. doi: 10.1016/j.eururo.2018.04.027. Epub 2018 May 3. No abstract available.

47.

Psychometric evaluation of the Swedish version of Rosenberg's self-esteem scale.

Eklund M, Bäckström M, Hansson L.

Nord J Psychiatry. 2018 Jul;72(5):318-324. doi: 10.1080/08039488.2018.1457177. Epub 2018 Apr 1.

PMID:
29607717
49.

Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy.

Sahlström T, Eklund M, Timpka J, Henriksen T, Nyholm D, Odin P.

Acta Neurol Scand. 2018 Jul;138(1):78-84. doi: 10.1111/ane.12929. Epub 2018 Mar 22.

PMID:
29569237
50.

Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.

Wallerstedt A, Strom P, Gronberg H, Nordstrom T, Eklund M.

J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036.

PMID:
29548030

Supplemental Content

Loading ...
Support Center